0001477932-22-006861.txt : 20220913 0001477932-22-006861.hdr.sgml : 20220913 20220913161512 ACCESSION NUMBER: 0001477932-22-006861 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220725 FILED AS OF DATE: 20220913 DATE AS OF CHANGE: 20220913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson Robert Steven CENTRAL INDEX KEY: 0001412747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55908 FILM NUMBER: 221240909 MAIL ADDRESS: STREET 1: 7633 E. 63RD PLACE, #220 CITY: TULSA STATE: OK ZIP: 74133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp. CENTRAL INDEX KEY: 0001643301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371765151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5805 SEPULVEDA BLVD., SUITE 801 CITY: SHERMAN OAKS STATE: CA ZIP: 91411 BUSINESS PHONE: 424-273-8675 MAIL ADDRESS: STREET 1: 5805 SEPULVEDA BLVD., SUITE 801 CITY: SHERMAN OAKS STATE: CA ZIP: 91411 FORMER COMPANY: FORMER CONFORMED NAME: Makkanotti Group Corp. DATE OF NAME CHANGE: 20150526 4 1 form4.xml FORM 4 X0306 4 2022-07-25-05:00 false 0001643301 Cure Pharmaceutical Holding Corp. CURR 0001412747 Davidson Robert Steven C/O CURE PHARMACEUTICAL HOLDING CORP. 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 true false false false Common Stock 2022-07-25-05:00 4 A false 220795 0 A 1283244 D This late filing is due to an inadvertent administrative error and not any error of the Reporting Person. Represents the grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan pursuant to the Issuer's Non-Employee Director Compensation Policy. The RSUs will vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service through the vesting date. The RSUs will vest in full immediately prior to the consummation of a change in control of the Issuer. The RSUs will be settled in shares of the Issuer's common stock upon vesting. /s/ Joel M. Bennett, Attorney-in-Fact for Robert Steven Davidson 2022-09-13-05:00